Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or Dyslipidemia

NCT02458287 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

299

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipidemia

Interventions

BIOLOGICAL: Bococizumab 150mg
BIOLOGICAL: Bococizumab 75mg
BIOLOGICAL: Bococizumab 150mg placebo
BIOLOGICAL: Bococizumab 75mg placebo

Sponsor

Pfizer